Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins

Nature Chemical Biology

Volumn 3, Issue 9, 2007, Pages 565-569

  Macheboeuf, Pauline ^a   Fischer, Delphine S ^b   Brown Jr , Tom ^b   Zervosen, Astrid ^c   Luxen, André ^c   Joris, Bernard ^c   Dessen, Andréa ^a   Schofield, Christopher J ^b  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^b Chemistry Research Laboratory   (United Kingdom)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ANTIBIOTIC AGENT; BETA LACTAM; CEFOTAXIME; CYCLOSERINE; GAMMA LACTONE DERIVATIVE; LACTIVICIN; PENICILLIN BINDING PROTEIN; PENICILLIN G; PHENOXYACETYLLACTIVICIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTALLOGRAPHY; DRUG ISOLATION; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 34548093798     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.2007.21     Document Type: Article

References (28)

1. Macheboeuf, P., Contreras-Martel, C., Job, V., Dideberg, O. & Dessen, A. Penicillin Binding Proteins: Key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol. Rev. 30, 673-691 (2006).
2. Nozaki, Y. et al. Binding of a non-β-lactam antibiotic to penicillin-binding proteins. Nature 325, 179-180 (1987).
3. Nozaki, Y., Katayama, N., Harada, S., Ono, H. & Okazaki, H. Lactivicin, a naturally occuring non-β-lactam antibiotic having β-lactam-like action: Biological activities and mode of action. J. Antibiot. (Tokyo) 42, 84-93 (1989).
4. Harada, S. et al. Structure of lactivicin, an antibiotic having a new nucleus and similar biological activities to β-lactam antibiotics. Tetrahedr. Lett. 27, 6229-6232 (1986).
5. Schuchat, A. et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337, 970-976 (1997).
6. Bronzwaer, S.L. et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8, 278-282 (2002).
7. Page, M.I. The Chemistry of β-Lactams (ed. Page, M.I.) (Blackie, Glasgow, 1992).
8. Harada, S. et al. Chemistry of a new antibiotic: Lactivicin. Tetrahedron 44, 6589-6606 (1988).
9. Inui, T., Oshida, T., Endo, T. & Matsushita, T. Potent bacteriolytic activity of ritipenem associated with a characteristic profile of affinities for penicillin-binding proteins of Haemophilus influenzae. Antimicrob. Agents Chemother. 43, 2534-2537 (1999).
10. Hakenbeck, R. et al. Penicillin-binding proteins in beta-lactam-resistant Streptococcus pneumoniae. Microb. Drug Resist. 5, 91-99 (1999).
11. Chesnel, L. et al. The structural modifications induced by the M339F substitution in PBP2x from Streptococcus pneumoniae further decreases the susceptibility to β-lactams of resistant strains. J. Biol. Chem. 278, 44448-44456 (2003).
12. Macheboeuf, P. et al. Active site restructuring regulates ligand recognition in class A penicillin-binding proteins. Proc. Natl. Acad. Sci. USA 102, 577-582 (2005).
13. Imming, P., Klar, B. & Dix, D. Hydrolytic stability versus ring size in lactams: Implications for the development of lactam antibiotics and other serine protease inhibitors. J. Med. Chem. 43, 4328-4331 (2000).
14. Wilmouth, R.C. et al. Mechanistic insights into the inhibition of serine proteases by monocyclic lactams. Biochemistry 38, 7989-7998 (1999).
15. Brown, R.P.A., Aplin, R.T. & Schofield, C.J. Inhibition of TEM-2 β-lactamase from Escherichia coli by clavulanic acid: Observation of intermediates by electrospray ionization mass spectrometry. Biochemistry 35, 12421-12432 (1996).
16. Imtiaz, U. et al. Inactivation of class-A β-lactamases by clavulanic acid - the role of arginine-244 in a proposed nonconcerted sequence of events. J. Am. Chem. Soc. 115, 4435-4442 (1993).
17. Llinás, A. et al. Inactivation of bacterial DD-peptidase by β-sultams. Biochemistry 44, 7738-7746 (2005).
18. Lakaye, B. et al. Synthesis, purification and kinetic properties of fluorescein-labelled penicillins. Biochem. J. 300, 141-145 (1994).
19. Carapito, R., Chesnel, L., Vernet, T. & Zapun, A. Pneumococcal β-lactam resistance due to a conformational change in penicillin-binding protein 2x. J. Biol. Chem. 281, 1771-1777 (2006).
20. Natsugari, H., Kawano, Y., Morimoto, A. & Yoshioka, K. Antibiotic 2-(3-oxo-2-isoxazolidinyl)-5-oxo-2-tetrahydrofuran-carboxylates. US Patent 4,851,422 (1989).
21. Ghuysen, J.M., Frère, J.M., Leyh-Bouille, M., Nguyen-Disteche, M. & Coyette, J. Active-site-serine D-alanyl-D-alanine-cleaving-peptidase- catalysed acyl-transfer reactions. Procedures for studying the penicillin-binding proteins of bacterial plasma membranes. Biochem. J. 235, 159-165 (1986).
22. Adam, M., Damblon, C., Plaitin, B., Christiaens, L. & Frère, J.M. Chromogenic depsipeptide substrates for beta-lactamases and penicillin-sensitive DD-peptidases. Biochem. J. 270, 525-529 (1990).
23. De Meester, F. et al. Automated analysis of enzyme inactivation phenomena. Application to beta-lactamases and DD-peptidases. Biochem. Pharmacol. 36, 2393-2403 (1987).
24. Kabsch, W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 26, 795-800 (1993).
25. Navaza, J. Implementation of molecular replacement in AMoRe. Acta Crystallogr. Sect. D Biol. Crystallogr. 57, 1367-1372 (2001).
26. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126-2132 (2004).
27. Collaborative Computational Project 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 760-763 (1994).
28. Brünger, A. Crystallography & NMR system: A new software for macromolecular structure determination. Acta Crystallogr. Sect. D. Biol. Crystallogr. 54, 905-921 (1998).